Rutgers Cancer Institute of New Jersey: New Data Informs Treatment of Blood Cancer During Pregnancy
June 01, 2023
June 01, 2023
NEW BRUNSWICK, New Jersey, June 1 (TNSjou) -- Rutgers Cancer Institute of New Jersey issued the following news:
* * *
Fighting relapsed/refractory lymphoma during pregnancy requires critical decision-making from patients and providers, yet prior to this study, no data existed to inform these choices
* * *
Today, Blood Advances published a study revealing that patients with relapsed/refractory (r/r) lymphoma during pregnancy experienced a progre . . .
* * *
Fighting relapsed/refractory lymphoma during pregnancy requires critical decision-making from patients and providers, yet prior to this study, no data existed to inform these choices
* * *
Today, Blood Advances published a study revealing that patients with relapsed/refractory (r/r) lymphoma during pregnancy experienced a progre . . .